Literature DB >> 29656939

Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib.

Alessia Mennitto1, Elena Verzoni1, Giorgia Peverelli1, Alessandra Alessi2, Giuseppe Procopio3.   

Abstract

Entities:  

Keywords:  Cabozantinib; Kidney cancer; Positron emission tomography; Renal collecting (Bellini) duct carcinoma; Targeted therapy

Mesh：

Substances：

Year:  2018        PMID： 29656939     DOI： 10.1016/j.clgc.2018.03.010

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  7 in total

1.  Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

Authors:  Nieves Martínez Chanzá; Wanling Xie; Mehmet Asim Bilen; Hannah Dzimitrowicz; Jarred Burkart; Daniel M Geynisman; Archana Balakrishnan; I Alex Bowman; Rohit Jain; Walter Stadler; Yousef Zakharia; Vivek Narayan; Benoit Beuselinck; Rana R McKay; Abhishek Tripathi; Russell Pachynski; Andrew W Hahn; JoAnn Hsu; Sumit A Shah; Elaine T Lam; Tracy L Rose; Anthony E Mega; Nicholas Vogelzang; Michael R Harrison; Amir Mortazavi; Elizabeth R Plimack; Ulka Vaishampayan; Hans Hammers; Saby George; Naomi Haas; Neeraj Agarwal; Sumanta K Pal; Sandy Srinivas; Benedito A Carneiro; Daniel Y C Heng; Dominick Bosse; Toni K Choueiri; Lauren C Harshman
Journal:  Lancet Oncol       Date:  2019-02-28       Impact factor: 41.316

2.  Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).

Authors:  Giuseppe Procopio; Pierangela Sepe; Melanie Claps; Sebastiano Buti; Maurizio Colecchia; Patrizia Giannatempo; Valentina Guadalupi; Luigi Mariani; Luca Lalli; Giovanni Fucà; Filippo de Braud; Elena Verzoni
Journal:  JAMA Oncol       Date:  2022-06-01       Impact factor: 33.006

3.  A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma.

Authors:  Chelsea K Osterman; Tracy L Rose
Journal:  Kidney Cancer       Date:  2020-03-30

4.  Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study.

Authors:  Chaopeng Tang; Yulin Zhou; Silun Ge; Xiaoming Yi; Huichen Lv; Wenquan Zhou
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244

5.  Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.

Authors:  Ruotao Xiao; Cheng Liu; Wei He; Lulin Ma
Journal:  Biomed Res Int       Date:  2021-11-11       Impact factor: 3.411

6.  Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.

Authors:  Zoé Guillaume; Emeline Colomba; Jonathan Thouvenin; Carolina Saldana; Luca Campedel; Clément Dumont; Brigitte Laguerre; Denis Maillet; Cécile Vicier; Frédéric Rolland; Delphine Borchiellini; Philippe Barthelemy; Laurence Albiges; Edouard Auclin; Matthieu Roulleaux Dugage; Stéphane Oudard; Constance Thibault
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 7.  Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease.

Authors:  Cristina Suarez; David Marmolejo; Augusto Valdivia; Rafael Morales-Barrera; Macarena Gonzalez; Joaquin Mateo; Maria Eugenia Semidey; David Lorente; Enrique Trilla; Joan Carles
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.